Spanish Red Biotech Pipeline

MSD

Prevymis (Letermovir)

Type: Biodrugs/ Drugs
Therapeutic area: Infections
Indication: Prevention of CMV disease in D+/R- kidney transplant recipients
Phase: 3Phase III in Spain, 2Phase II, 1Phase I